Metelimumab

Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. Touted as a drug of the future, metelimumab was dropped from further development in favour of fresolimumab, which is currently being developed by Genzyme.

单词	Metelimumab
释义	Metelimumab 英语百科 Metelimumab Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. Touted as a drug of the future, metelimumab was dropped from further development in favour of fresolimumab, which is currently being developed by Genzyme.
随便看	Diterpenes,Abietane Diterpenes,Cembrane Diterpenes,Clerodane Diterpenes,Kaurane Diterpenes,Labdane Diterpenes,Pimarane diterpenic Diterpenoid diterpenoid alkaloid diterpenoide dilactone diterpenoide triepoxides diterpenoid resin acid diterpenoids diterra di tertairy butyl cresol di tert amylhydroquinone ditertamylhydroquinone di tert butyl m cresol ditertbutylmcresol di tert butyl nitroxide ditertbutylparacresol di tert butyl peroxide ditertbutyl peroxide ditertbutyl peroxyphthalate di tert butyl peroxyphthalate